This issue of AJRCCM (pp. 773–780) features a randomized controlled trial (RCT)(1) to add
to the growing database of continuous positive airway pressure (CPAP) treatment for …

The minimal disease severity at which patients with the sleep apnea/hypopnea syndrome
(SAHS) gain benefit from treatment is not well characterized, although a pilot study of …

A common clinical dilemma faced by sleep physicians is in deciding the level of severity at
which patients with obstructive sleep apnea (OSA) should be treated. There is particular …

Continuous positive airway pressure (CPAP) therapy has been regarded for more than a
decade by those in the field as the treatment of choice for the sleep apnoea/hypopnoea …

Application of continuous positive airway pressure (CPAP) as the standard treatment for
sleep apnea/hypopnea syndrome (SAHS) is a moot point. Studies on the effectiveness of …

Obstructive sleep apnea (OSA) is one of the world's most common chronic respiratory
illnesses, affecting perhaps a billion people worldwide. 1 After 40 years of treatment of OSA …

Abstract Study Objective: To determine whether fixed-pressure or variable-pressure CPAP
was preferred by patients and gave better outcomes in patients with the obstructive sleep …

Continuous positive airway pressure (CPAP) is worldwide considered as the standard
treatment of sleep apnea/hypopnea syndrome (SAHS) although studies on the effectiveness …

Extract The recently published technology assessment of continuous positive airway
pressure (CPAP), prepared for the Agency for Healthcare Research and Quality (AHRQ) of …

Rationale: Twenty-eight percent of people with mild to moderate obstructive sleep apnea
experience daytime sleepiness, which interferes with daily functioning. It remains unclear …